{
  "id": "fa098752e4fe028308cbdf90117532caadac16c9",
  "title": "Novo Nordisk faces a defining year in the obesity drug market. Itâ€™s off to a dramatic start",
  "summary_full": "The Danish drugmaker kicked off 2026 with its explosive obesity pill launch, but recent challenges have centered around protecting its market share.",
  "summary_public": "The Danish drugmaker kicked off 2026 with its explosive obesity pill launch, but recent challenges have centered around protecting its market share.",
  "url": "https://www.cnbc.com/2026/02/11/novo-nordisk-faces-defining-year-in-the-obesity-drug-market.html",
  "published_at": "2026-02-11T22:01:42+00:00",
  "source": "International: Top News And Analysis",
  "language": "en",
  "countries_detected": [
    "DK"
  ],
  "countries_scored": [
    "DK"
  ],
  "llm_version": "v3-eu",
  "llm_perspective": "EU",
  "llm_attempted_at": "2026-02-13T10:02:20+00:00",
  "sentiment_by_country": {
    "DK": {
      "label": "neutral",
      "confidence": 0.3,
      "evidence": "Danish drugmaker kicked off 2026"
    }
  },
  "processed_at": "2026-02-13T10:02:20+00:00"
}